Andrew Maxwell

As the Founder of Chatsworth Associates, Andrew has worked with innovators, entrepreneurs, and established business owners to plan and execute over $250m in equity raisings.
Chatsworth Associates is a boutique advisory firm providing strategic advice to business owners in emerging and high growth companies innovating in the Bio-Medical, Medical Device, Mobile Health, Health IT, Agtech, Hospitality, Food Service and Food Technology sectors.
For 10 years, Andrew led the global growth of Global Kinetics Corporation Ltd (GKC) as Managing Director and CEO.
The GKC team commercialised research emanating from the Florey Institute of Neuroscience and Mental Health and created a global company with a market-leading product for the remote measurement and reporting of the movement disorder symptoms of Parkinson’s disease – the Parkinson’s KinetiGraph (PKG).
As CEO of ESCOR Private Equity (a Smorgon Family Company), Andrew established and managed a $40m investment fund focused on the IT, Internet, Biotech, Healthcare, and Manufacturing technology sectors.
Andrew has a Master of Accounting and an MBA from Bond University.
He is currently an associate member of the Association of Certified Practicing Accountants, a member of the Australian Institute of Company Directors and the Australian Investment Council.